243 related articles for article (PubMed ID: 11513007)
1. XANES spectroscopy of a single neuron from a patient with Parkinson's disease.
Yoshida S; Ektessabi A; Fujisawa S
J Synchrotron Radiat; 2001 Mar; 8(Pt 2):998-1000. PubMed ID: 11513007
[TBL] [Abstract][Full Text] [Related]
2. Investigations of differences in iron oxidation state inside single neurons from substantia nigra of Parkinson's disease and control patients using the micro-XANES technique.
Chwiej J; Adamek D; Szczerbowska-Boruchowska M; Krygowska-Wajs A; Wojcik S; Falkenberg G; Manka A; Lankosz M
J Biol Inorg Chem; 2007 Feb; 12(2):204-11. PubMed ID: 17120075
[TBL] [Abstract][Full Text] [Related]
3. Analysis of neuronal iron deposits in Parkinson's disease brain tissue by synchrotron x-ray spectromicroscopy.
Brooks J; Everett J; Lermyte F; Tjendana Tjhin V; Sadler PJ; Telling N; Collingwood JF
J Trace Elem Med Biol; 2020 Dec; 62():126555. PubMed ID: 32526631
[TBL] [Abstract][Full Text] [Related]
4. Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry.
Biesemeier A; Eibl O; Eswara S; Audinot JN; Wirtz T; Pezzoli G; Zucca FA; Zecca L; Schraermeyer U
J Neurochem; 2016 Jul; 138(2):339-53. PubMed ID: 27121280
[TBL] [Abstract][Full Text] [Related]
5. Neuromelanin-containing neurons of the substantia nigra accumulate iron and aluminum in Parkinson's disease: a LAMMA study.
Good PF; Olanow CW; Perl DP
Brain Res; 1992 Oct; 593(2):343-6. PubMed ID: 1450944
[TBL] [Abstract][Full Text] [Related]
6. Study of Cu chemical state inside single neurons from Parkinson's disease and control substantia nigra using the micro-XANES technique.
Chwiej J; Adamek D; Szczerbowska-Boruchowska M; Krygowska-Wajs A; Bohic S; Lankosz M
J Trace Elem Med Biol; 2008; 22(3):183-8. PubMed ID: 18755393
[TBL] [Abstract][Full Text] [Related]
7. Selectivity of melaninized nigra-striatal dopamine neurons to degeneration in Parkinson's disease may depend on iron-melanin interaction.
Ben-Shachar D; Youdim MB
J Neural Transm Suppl; 1990; 29():251-8. PubMed ID: 2193109
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early-stage Parkinson's disease.
Reimão S; Ferreira S; Nunes RG; Pita Lobo P; Neutel D; Abreu D; Gonçalves N; Campos J; Ferreira JJ
Eur J Neurol; 2016 Feb; 23(2):368-74. PubMed ID: 26518135
[TBL] [Abstract][Full Text] [Related]
9. Neuromelanin associated redox-active iron is increased in the substantia nigra of patients with Parkinson's disease.
Faucheux BA; Martin ME; Beaumont C; Hauw JJ; Agid Y; Hirsch EC
J Neurochem; 2003 Sep; 86(5):1142-8. PubMed ID: 12911622
[TBL] [Abstract][Full Text] [Related]
10. Is Parkinson's disease a progressive siderosis of substantia nigra resulting in iron and melanin induced neurodegeneration?
Youdim MB; Ben-Shachar D; Riederer P
Acta Neurol Scand Suppl; 1989; 126():47-54. PubMed ID: 2618593
[TBL] [Abstract][Full Text] [Related]
11. In vivo detection of iron and neuromelanin by transcranial sonography: a new approach for early detection of substantia nigra damage.
Zecca L; Berg D; Arzberger T; Ruprecht P; Rausch WD; Musicco M; Tampellini D; Riederer P; Gerlach M; Becker G
Mov Disord; 2005 Oct; 20(10):1278-85. PubMed ID: 15986424
[TBL] [Abstract][Full Text] [Related]
12. The enigma of neuromelanin in Parkinson's disease substantia nigra.
Youdim MB; Ben-Shachar D; Riederer P
J Neural Transm Suppl; 1994; 43():113-22. PubMed ID: 7884393
[TBL] [Abstract][Full Text] [Related]
13. The role of transition metals in the pathogenesis of Parkinson's disease.
Kienzl E; Puchinger L; Jellinger K; Linert W; Stachelberger H; Jameson RF
J Neurol Sci; 1995 Dec; 134 Suppl():69-78. PubMed ID: 8847547
[TBL] [Abstract][Full Text] [Related]
14. Cell specific quantitative iron mapping on brain slices by immuno-µPIXE in healthy elderly and Parkinson's disease.
Friedrich I; Reimann K; Jankuhn S; Kirilina E; Stieler J; Sonntag M; Meijer J; Weiskopf N; Reinert T; Arendt T; Morawski M
Acta Neuropathol Commun; 2021 Mar; 9(1):47. PubMed ID: 33752749
[TBL] [Abstract][Full Text] [Related]
15. Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: an X-ray microanalysis.
Hirsch EC; Brandel JP; Galle P; Javoy-Agid F; Agid Y
J Neurochem; 1991 Feb; 56(2):446-51. PubMed ID: 1988548
[TBL] [Abstract][Full Text] [Related]
16. Metal dyshomeostasis in the substantia nigra of patients with Parkinson's disease or multiple sclerosis.
Carmona A; Carboni E; Gomes LC; Roudeau S; Maass F; Lenz C; Ortega R; Lingor P
J Neurochem; 2024 Feb; 168(2):128-141. PubMed ID: 38178798
[TBL] [Abstract][Full Text] [Related]
17. In vivo detection of iron and neuromelanin by transcranial sonography--a new approach for early detection of substantia nigra damage.
Berg D
J Neural Transm (Vienna); 2006 Jun; 113(6):775-80. PubMed ID: 16755382
[TBL] [Abstract][Full Text] [Related]
18. Substantia Nigra Neuromelanin as an Imaging Biomarker of Disease Progression in Parkinson's Disease.
Fabbri M; Reimão S; Carvalho M; Nunes RG; Abreu D; Guedes LC; Bouça R; Lobo PP; Godinho C; Coelho M; Gonçalves NC; Rosa MM; Antonini A; Ferreira JJ
J Parkinsons Dis; 2017; 7(3):491-501. PubMed ID: 28671143
[TBL] [Abstract][Full Text] [Related]
19. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
20. Iron-binding characteristics of neuromelanin of the human substantia nigra.
Double KL; Gerlach M; Schünemann V; Trautwein AX; Zecca L; Gallorini M; Youdim MB; Riederer P; Ben-Shachar D
Biochem Pharmacol; 2003 Aug; 66(3):489-94. PubMed ID: 12907248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
